Community Health Centers, Hospitals Eye Suit Over 340B Policies

By Michelle M. Stein / September 8, 2020 at 7:29 PM
Community health centers are prepping legal action in a bid to avert drug manufacturers’ limitations on 340B discounts accessed via contract pharmacies, as two hospital groups also consider their legal options and the Health Resources and Services Administration weighs whether manufacturers’ policies violate the 340B statute and sanctions should apply. Over the past few months, AstraZeneca , Sanofi , Merck and Lilly have acted to limit or stop 340B discounts accessed through contract pharmacies or to require additional data from...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.